Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 243, "treatment_name": "C21", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

July 30, 2021, 1:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

July 23, 2021, 11 p.m. oms

[]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: C21: IMP will be administered twice daily orally for 7 days from Visit 2 to Visit 8 as follows:1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo: IMP will be administered twice daily orally for 7 days from visit 2 to visit 8 as follows: 1. Morning dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting 2 Afternoon/evening dose: Two 50 mg capsules to be taken with a glass of water after minimum 2 hours fasting Subjects will be required not to eat anything for 1 hour after taking the IMP.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]